Ignite Creation Date:
2024-05-05 @ 5:22 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00449722
Status:
COMPLETED
Last Update Posted:
2016-01-21
First Post:
2007-03-20
Brief Title:
OD vs TID Dosing With Mesalazine Granules in Active Ulcerative Colitis
Sponsor:
Dr Falk Pharma GmbH
Organization:
Dr Falk Pharma GmbH
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-07
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
2006-06
Completion Date Type:
ACTUAL
First Submit Date:
2007-03-20
First Submit QC Date:
March 20 2007
Study First Post Date:
2007-03-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-01-20
Last Update Post Date:
2016-01-21
Last Update Post Date Type:
ESTIMATED